Market Overview:
The global blood bank analyzers market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for blood bank analyzers due to the rising prevalence of chronic diseases, growing number of surgical procedures, and increasing awareness about blood donation and its benefits. In addition, technological advancements in blood bank analyzers are also contributing to the growth of this market. On the basis of type, the global blood bank analyzers market is segmented into fully automatic analyzers and semi-automaticanalyzers. The fully automaticanalyzer segment is expected to grow at a higher CAGR thanthesemi-automaticanalyzer segment duringthe forecast period from 2018to 2030 owingtoits advantages such as easeof useand accuracyin results.
Product Definition:
Blood bank analyzers are medical devices used to measure various components of blood, including hemoglobin levels and hematocrits. They are important for ensuring the quality of donated blood and helping to diagnose conditions such as anemia.
Fully Automatic Analyzers:
Fully automatic analyzers are instruments that perform a series of tests and then give a final result. These analyzers have the ability to analyze different types of samples without any intervention from a person. Fully automatic blood bank analyzer is an instrument used for testing the quality of blood and its components such as RBCs, WBCs, platelets etc. This device has various advantages over semi-automatic devices including high accuracy, reliability and faster analysis time among others.
Semi-Automatic Analyzers:
Semi-automatic analyzers are used in blood bank analyzers to perform certain tests such as hemoglobin, hematocrit, and serum electrophoresis. These devices help in performing the analysis without any human intervention which is a big plus for many doctors and patients.
These analyzers also provide results within a few minutes which is very much helpful for the doctors who want quick results so that they can make decisions regarding their treatment options.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. This segment includes home care settings, clinics and hospitals at localities where blood cannot be stored or processed centrally. Analyzers for this application have been installed at these locations so that they can process donations and perform tests on a regular basis to track the health of donors across the globe. Semi-automatic analyzers are preferred for such applications as they require less monitoring and can be used without any human intervention over long periods; however, fully automatic analyzers are preferred as they offer higher accuracy with minimal effort required from operators every day.
Regional Analysis:
North America dominated the global blood bank analyzers market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high adoption rate of advanced technology, and increasing demand for organ donation drives across this region. Moreover, a rise in chronic diseases that require long term treatment and an increase in surgical procedures are also contributing toward regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure due to rising investment by governments and private players coupled with growing awareness about blood donations among people especially students & young generation is driving towards Blood Donor Centers (BDCs) which will further drive market demand for these analyzers over next eight years.
Growth Factors:
- Increasing demand for safe and quality blood transfusion: The global Blood Bank Analyzers market is expected to grow at a CAGR of 6.5% during the forecast period owing to the increasing demand for safe and quality blood transfusion. This is mainly due to the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases across the globe.
- Technological advancements in Blood Bank Analyzers: The technological advancements in Blood Bank Analyzers are expected to drive the growth of this market during the forecast period. For instance, manufacturers are introducing analyzers that can detect various infections and abnormalities in donated blood samples quickly and accurately. This is helping hospitals improve their overall efficiency by reducing turnaround time for results reporting.
- Growing number of blood donation camps: The growing number of blood donation camps is another major factor driving growth in this market during the forecast period 2017-2025 . Donated blood needs to be screened properly before it can be used for transfusions; hence, there exists a large potential market for Blood Bank Analyzers globally . In addition, with governments all over promoting voluntary donations through awareness campaigns & schemes , there has been an increase in both donor base as well as donations collected by various organizations worldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Bank Analyzers Market Research Report
By Type
Fully Automatic Analyzers, Semi-Automatic Analyzers
By Application
Hospitals, Clinics, Others
By Companies
Abbott, Beckman Coulter, BD, Biokit, BioMerieux, Bio-Rad, DiaSorin, Fujirebio, HOLOGIC, Roche, Siemens, Johnson & Johnson, Tecan, Novartis, Diagast, Grifols, Immucor, Innogenetics, Orchid CellMark, Proteome Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Blood Bank Analyzers Market Report Segments:
The global Blood Bank Analyzers market is segmented on the basis of:
Types
Fully Automatic Analyzers, Semi-Automatic Analyzers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Beckman Coulter
- BD
- Biokit
- BioMerieux
- Bio-Rad
- DiaSorin
- Fujirebio
- HOLOGIC
- Roche
- Siemens
- Johnson & Johnson
- Tecan
- Novartis
- Diagast
- Grifols
- Immucor
- Innogenetics
- Orchid CellMark
- Proteome Sciences
Highlights of The Blood Bank Analyzers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fully Automatic Analyzers
- Semi-Automatic Analyzers
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Bank Analyzers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood Bank Analyzers are machines that help doctors and nurses determine the blood types of patients.
Some of the major players in the blood bank analyzers market are Abbott, Beckman Coulter, BD, Biokit, BioMerieux, Bio-Rad, DiaSorin, Fujirebio, HOLOGIC, Roche, Siemens, Johnson & Johnson, Tecan, Novartis, Diagast, Grifols, Immucor, Innogenetics, Orchid CellMark, Proteome Sciences.
The blood bank analyzers market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Bank Analyzers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Blood Bank Analyzers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Blood Bank Analyzers Market - Supply Chain
4.5. Global Blood Bank Analyzers Market Forecast
4.5.1. Blood Bank Analyzers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Blood Bank Analyzers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Blood Bank Analyzers Market Absolute $ Opportunity
5. Global Blood Bank Analyzers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Blood Bank Analyzers Market Size and Volume Forecast by Type
5.3.1. Fully Automatic Analyzers
5.3.2. Semi-Automatic Analyzers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Blood Bank Analyzers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Blood Bank Analyzers Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Blood Bank Analyzers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Blood Bank Analyzers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Blood Bank Analyzers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Blood Bank Analyzers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Blood Bank Analyzers Demand Share Forecast, 2019-2026
9. North America Blood Bank Analyzers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Blood Bank Analyzers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Blood Bank Analyzers Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Blood Bank Analyzers Market Size and Volume Forecast by Type
9.7.1. Fully Automatic Analyzers
9.7.2. Semi-Automatic Analyzers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Blood Bank Analyzers Demand Share Forecast, 2019-2026
10. Latin America Blood Bank Analyzers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Blood Bank Analyzers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Blood Bank Analyzers Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Blood Bank Analyzers Market Size and Volume Forecast by Type
10.7.1. Fully Automatic Analyzers
10.7.2. Semi-Automatic Analyzers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Blood Bank Analyzers Demand Share Forecast, 2019-2026
11. Europe Blood Bank Analyzers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Blood Bank Analyzers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Blood Bank Analyzers Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Blood Bank Analyzers Market Size and Volume Forecast by Type
11.7.1. Fully Automatic Analyzers
11.7.2. Semi-Automatic Analyzers
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Pojections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Blood Bank Analyzers Demand Share, 2019-2026
12. Asia Pacific Blood Bank Analyzers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Blood Bank Analyzers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Blood Bank Analyzers Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Blood Bank Analyzers Market Size and Volume Forecast by Type
12.7.1. Fully Automatic Analyzers
12.7.2. Semi-Automatic Analyzers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Blood Bank Analyzers Demand Share, 2019-2026
13. Middle East & Africa Blood Bank Analyzers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Blood Bank Analyzers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Blood Bank Analyzers Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Blood Bank Analyzers Market Size and Volume Forecast by Type
13.7.1. Fully Automatic Analyzers
13.7.2. Semi-Automatic Analyzers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Blood Bank Analyzers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Blood Bank Analyzers Market: Market Share Analysis
14.2. Blood Bank Analyzers Distributors and Customers
14.3. Blood Bank Analyzers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Beckman Coulter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biokit
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BioMerieux
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. DiaSorin
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fujirebio
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. HOLOGIC
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Roche
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Siemens
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Johnson & Johnson
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Tecan
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Novartis
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Diagast
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Grifols
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Immucor
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Innogenetics
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Orchid CellMark
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Proteome Sciences
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook